AstraZeneca Pharma India Limited — Others, 09-06-2025: Cessation

AstraZeneca Pharma India has announced a leadership change with Dr. Sanjeev Kumar Panchal resigning as Managing Director to assume a global role in the US, effective June 30, 2025. Mr. Praveen Rao Akkinepally will succeed him from July 1, 2025, on a three-year term. With over 20 years in oncology and biopharmaceuticals, Praveen is recognized for driving growth, successful brand launches, and championing cancer care policy in India. This leadership transition underscores the company’s commitment to oncology and expanding its market presence.